Clinical Trial Management System (CTMS) Market Size, Share, Leading Players and Analysis up to 2026
February 09, 2022
Stratview Research has launched a new report, titled Clinical Trial Management System (CTMS) Market, By Component (Software, Services), Delivery Mode (Cloud-based (SaaS) CTMS, Licensed Enterprise (On-premise) CTMS, Web-based (Hosted) CTMS), Type (Enterprise, Site), End User (Clinical Research Organizations (CROs), Medical Device Firms, Pharmaceutical & Biotechnology Firms, Other) and Region.
Covid-19 Impact Analysis:
Covid-19 has highly impacted the market dynamics, competition, and supply chain of almost all industries. The revenues have gone down in 2020 and are expected to resume an uptrend gradually from 2021 and continue to grow further. The report covers all the segments that were affected by the pandemic.
According to the report, The Clinical Trial Management System (CTMS) Market is expected to grow from USD 810.3 million in 2020 to USD 1597.5 million by 2026 at a CAGR of over 12.2% during the forecast period.
Market Segments' Analysis
Based on end users, the market has been segmented into clinical research organizations (CROS), medical device firms, pharmaceutical & biotechnology firms, and others. The clinical research organizations segment accounted for the largest market share in 2020 and is projected to register significant CAGR during the review period.
Geographically, the market in North America accounted for the largest market share in 2020 and is expected to register significant CAGR during the review period. The market growth can be attributed to the high demand for advanced IT solutions in the healthcare sector coupled with the presence of key market players such as ArisGlobal LLC (US) and Bioclinica (US). The market in Asia-Pacific is expected to be driven by the rising adoption of CTMS in developing countries, particularly China and India.
Key Players
The following are the key players in the Clinical Trial Management System (CTMS) Market-
- ArisGlobal LLC (US)
- Bioclinica (US)
- Bio-Optronics (US)
- DataTrak International, Inc. (US)
- Document Solutions Group (US)
- Eclinforce Inc (US)
- Advarra, Inc. (US)
- Medidata Solutions (US)
- MedNet Solutions, Inc. (US)
- Oracle Corporation (US)
- Parexel International (US)
- Veeva Systems Inc. (US)
Frequently Asked Questions –
This report provides vital information and valuable insights, enabling the users to identify the strategic growth opportunities in the market. The report aims at answering the following key questions:
- What is the current and future market size of Clinical Trial Management System (CTMS) Market?
- How has the COVID-19 pandemic impacted the market? How fast is it expected to recover?
- What will be the short and long-term effects of the pandemic?
- How are other market factors affecting the market dynamics?
- Which segments offer high-growth opportunities in the long run?
- How fierce is the Clinical Trial Management System (CTMS) Market competition?
- What are the key emerging trends and unmet needs in the present market?
- What are the strategic growth opportunities and key success factors?
Read the full report: https://www.stratviewresearch.com/2407/Clinical-Trial-Management-System-(CTMS)-Market.html
Custom Research: Stratview Research offers custom research services across the sectors. In case of any custom research requirement or any further query related to the report, please send your inquiry to sales@stratviewresearch.com. You may also connect with our market experts at +1-313-307-4176.
About Stratview Research
Stratview Research is a global market research firm that provides high-quality market research reports, market entry strategies, growth strategies, and more. We in-depth market research studies, to help the users obtain grainy level clarity on present business trends and probable future developments. At Stratview Research, the market experts are committed to providing custom solutions best fit for strategy development and implementation to achieve visible growth.